US Patent Issued to SHANGHAI HANSOH BIOMEDICAL, JIANGSU HANSOH PHARMACEUTICAL GROUP on Dec. 16 for "Nitrogen-containing heterocyclic derivatives, method therefor and application therefor as inhibitors of KRAS G12C for the treatment of cancers" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,396, issued on Dec. 16, was assigned to SHANGHAI HANSOH BIOMEDICAL Co. LTD. (Shanghai) and JIANGSU HANSOH PHARMACEUTICAL GROUP Co. LTD. (Lianyungang, China).

"Nitrogen-containing heterocyclic derivatives, method therefor and application therefor as inhibitors of KRAS G12C for the treatment of cancers" was invented by Shiqiang Liu (Shanghai), Yongsheng Wang (Shanghai), Yida Yuan (Shanghai), Cheng Cen (Shanghai) and Rudi Bao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a nitrogen-containing heterocyclic derivative regulator, a preparation method therefor and an application thereof. In particular, disclosed are a compound as r...